These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 6421041)
1. Prolactin secretion from human prolactinomas perifused in vitro: effect of TRH, prostaglandin E1, theophylline, dopamine and dopamine receptor blockers. Chihara K; Iwasaki J; Minamitani N; Kaji H; Kodama H; Fujita T; Shirataki K; Tamaki N; Matsumoto S Acta Endocrinol (Copenh); 1984 Jan; 105(1):6-13. PubMed ID: 6421041 [TBL] [Abstract][Full Text] [Related]
2. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. Ishibashi M; Yamaji T J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273 [TBL] [Abstract][Full Text] [Related]
4. [A study on the prolactin releasing mechanism using an in vitro perfusion system with a cell column of cultured rat anterior pituitary cells]. Kageyama J Nihon Naibunpi Gakkai Zasshi; 1984 Oct; 60(10):1243-54. PubMed ID: 6440813 [TBL] [Abstract][Full Text] [Related]
5. Prolactin secretion by mixed ACTH-prolactin pituitary adenoma cells in culture. Yamaji T; Ishibashi M; Teramoto A; Fukushima T Acta Endocrinol (Copenh); 1985 Apr; 108(4):456-63. PubMed ID: 2859725 [TBL] [Abstract][Full Text] [Related]
6. [The properties of prolactin secretion in patients with prolactin secreting pituitary adenomas]. Sato S Nihon Naibunpi Gakkai Zasshi; 1987 Aug; 63(8):947-60. PubMed ID: 3123284 [TBL] [Abstract][Full Text] [Related]
7. Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol, and somatostatin. Le Dafniet M; Lefebvre P; Barret A; Mechain C; Feinstein MC; Brandi AM; Peillon F J Clin Endocrinol Metab; 1990 Aug; 71(2):480-6. PubMed ID: 1974264 [TBL] [Abstract][Full Text] [Related]
8. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture. Ishibashi M; Yamaji T J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494 [TBL] [Abstract][Full Text] [Related]
9. D2 Dopamine receptor subtype mediates the inhibitory effect of dopamine on TRH-induced prolactin release from the bullfrog pituitary. Nakano M; Minagawa A; Hasunuma I; Okada R; Tonon MC; Vaudry H; Yamamoto K; Kikuyama S; Machida T; Kobayashi T Gen Comp Endocrinol; 2010 Sep; 168(2):287-92. PubMed ID: 20553721 [TBL] [Abstract][Full Text] [Related]
10. Evidence for dopamine-related and TRH-related pituitary TSH and PRL pools in patients with prolactinoma. Hanew K; Utsumi A; Sugawara A; Shimizu Y; Yoshinaga K Acta Endocrinol (Copenh); 1991 May; 124(5):545-52. PubMed ID: 1903012 [TBL] [Abstract][Full Text] [Related]
11. Perifusion studies of bromocriptine-treated and untreated macroprolactinomas: effects of dopamine, bromocriptine and TRH. Bevan JS; Burke CW Clin Endocrinol (Oxf); 1989 Jun; 30(6):667-80. PubMed ID: 2512041 [TBL] [Abstract][Full Text] [Related]
12. Hormonal regulation of prolactin release by human prolactinoma cells cultured in serum-free conditions. Jaquet P; Gunz G; Grisoli F Horm Res; 1985; 22(3):153-63. PubMed ID: 3932176 [TBL] [Abstract][Full Text] [Related]
13. Dynamics of prolactin secretion from diethylstilbestrol-induced rat prolactinoma tissue in vitro. Maas DL; Martinson DR; Erdmann MD; Wahle JS; Hagen TC Proc Soc Exp Biol Med; 1995 Nov; 210(2):150-5. PubMed ID: 7568285 [TBL] [Abstract][Full Text] [Related]
14. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants. Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947 [TBL] [Abstract][Full Text] [Related]
17. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat. Christian HC; Chapman LP; Morris JF J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102 [TBL] [Abstract][Full Text] [Related]
18. The effect of dopamine on thyrotropin-releasing hormone-induced prolactin secretion in vitro. Fagin KD; Neill JD Endocrinology; 1981 Dec; 109(6):1835-40. PubMed ID: 6796383 [TBL] [Abstract][Full Text] [Related]
19. Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants. Hashizume T; Onodera Y; Shida R; Isobe E; Suzuki S; Sawai K; Kasuya E; Nagy GM Domest Anim Endocrinol; 2009 Feb; 36(2):99-104. PubMed ID: 19070987 [TBL] [Abstract][Full Text] [Related]
20. Presence of high affinity dopamine receptors in estrone-induced, prolactin-secreting rat pituitary adenomas: a model for human prolactinomas. Eljarmak D; Marchisio AM; Lis M; Collu R Horm Res; 1985; 21(2):107-16. PubMed ID: 3920132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]